Issels Integrative Immuno-Oncology April 5, 2018  

National Institute of Health Considers Genomics Research of Critical Importance

Dear Friend,

As scientists learn more about how cancer cells operate, they use that knowledge to formulate more effective methods of cancer immunotherapy. For this reason, the National Institute of Health (NIH) considers genomics research to be a critical tool in the fight against cancer.

Why Genomics Research?

The National Cancer Institute (NCI) is the arm of the NIH devoted to cancer research and training. In 2012, the NCI founded the Center for Cancer Genomics (CCG) for the purpose of studying the role of altered genes in the development of cancer.

Cancer results from abnormal cell growth within the body. Genomics research helps scientists understand more about these abnormalities and how they drive cancer development, leading to more precise methods of diagnosis and treatment.

Benefits of Cancer Genomics Research

One example of the success of genomic research is the development of vemurafenib (trade name Zelboraf®), which was approved by the Food and Drug Administration (FDA) in 2011. Vemurafenib is a cancer treatment that targets a form of melanoma arising from a specific mutation in the BRAF gene.

As researchers survey and catalog the results of various projects over the years, they have uncovered genetic similarities between seemingly disparate forms of cancer. For instance, mutations in the HER2 gene have been revealed in breast, bladder, pancreatic and ovarian cancers.

Cancer Immunotherapy at Issels®

Genomic diagnostics are an important part of the Issels® comprehensive immunobiologic core treatment. These tests are invaluable in providing essential information to help us identify causes of the disease and develop personalized cancer immunotherapy programs.

Contact us to learn more about cancer vaccines and other treatments at Issels®.

National Institute of Health Considers Genomics Research of Critical Importance

Read more interesting articles on the "Issels Cancer Immunotherapy" news/blog posted every Tuesday and Thursday. Check It Out Now »

Built To Spread, Cancer May Change Genome to Proliferate More Easily

Researchers already know that cancer cells are often able to evade detection by the body's disease-fighting immune system. A recent study shows they may also streamline their genomes for faster replication. This information can be used to predict whether a tumor will be vulnerable to DNA-damaging immunotherapy for cancer. Ribosomal DNA, which is present in both healthy and cancerous cells, is the key. This DNA carries the code for ribosomes, which produce the proteins that are responsible for many cell functions.

Get the Full Story!

Epigenomics Research May Stop Progression of Late Stage Cancers

Research details announced recently gives new hope for late stage cancer patients: Mayo Clinic oncologists and an international team revealed that they may have found a way to stop the spread of late stage cancers using epigenomics and epigenetics research. Additionally, they may be able to use their research to soon identify people predisposed to certain cancers before early tumor formation.

Get the Full Story!

Videos – What Do Patients Say About Their Experience?

Watch videos of patients who share their own experiences at the Issels clinics with you. Listen to their stories and cancer journeys.

Get the Full Story!

Learn More

Testimonials »

Treatments »

Vaccines »

Statistics »

History »

Locations »

Contact Us »

Connect With Us:

Google +

Contact Info:

Phone: 888-447-7357


Treatments | Testimonials | Contact Us